Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Leerink Partners Initiates Coverage On Quest Diagnostics with Market Perform Rating, Announces Price Target of $135

Author: Benzinga Newsdesk | February 26, 2024 10:17am
Leerink Partners analyst Michael Cherny initiates coverage on Quest Diagnostics (NYSE:DGX) with a Market Perform rating and announces Price Target of $135.

Posted In: DGX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist